[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551733":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":45,"collaborators":18,"id":47,"slug":18,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":18,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":18,"enrollmentInfo":56,"targetDuration":18,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Cosmetique Active International","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"acneic participants group","OTHER","subjects with mild to moderate facial and truncal acne",[13],"Other: acneic participants group",[15],{"type":10,"name":9,"description":16,"armGroupLabels":17,"otherNames":18},"Application of Effaclar Duo+M to the face and trunk twice daily (morning and evening) after washing with the cleansing gel.",[9],null,[20],{"name":21,"affiliation":22,"role":23},"Renato Moura","Centre International de Développement Pharmaceutique (CIDP)","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Alessandro Nascimento","CONTACT","+55 21 98726-2046","a.nascimento@cidp-cro.com",[31],{"facility":32,"status":33,"city":34,"state":18,"zip":18,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"CIDP Brasil","RECRUITING","Rio de Janeiro","Brazil","BR",{"type":38,"coordinates":39},"Point",[40,41],-43.18223,-22.90642,{"lat":41,"lon":40},[44],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},{"type":46,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100551733",false,"NCT06463925","Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk","Evaluation of Effaclar Duo+M on Inflammatory and Non-Inflammatory Lesions in Subjects With Mild to Moderate Acne on Face and Trunk (Back and Chest)","Inclusion Criteria:\n\n* phototype I to VI\n* mild to moderate acne on the face and trunk\n\nExclusion Criteria:\n\n* cutaneous pathology on the studied zone other than acne\n* topical or systemic treatment during the previous weeks liable to interfere with the assessment of the acceptability and efficacy of the studied products",true,"ALL","18 Years",{"count":57,"type":58},65,"ESTIMATED","INTERVENTIONAL",[61],"NA","This single-center, open, non-randomized study aims the efficacy evaluation of Effaclar Duo+M and Effaclar+M Purifying foaming gel on total acne lesion count, pigmented lesions and scars for 6 months in subjects with mild to moderate facial and truncal acne.",[64],"Acne",[66,67,68],"facial and truncal acne","Effaclar Duo+M","acne lesions","2024-06-14",{"date":71,"type":72},"2024-06-18","ACTUAL",{"date":74,"type":72},"2023-12-07",{"date":76,"type":58},"2024-09",{"name":5,"class":6},1]